Quickly
Socially
Trending
CryptoADAR POONAWALLA
COVID-19 Vaccine: Serum Institute Of India and Bharat Biotech Issue Joint Statement, Adar Poonawalla Says 'This Should Clarify Any Miscommunication'
Oxford-AstraZeneca COVID-19 Vaccine to Cost Rs 219-292 to Government; Rs 438-584 in Private Market: Serum Institute of India
COVID-19 Vaccine Covishield Will Be Sold at Rs 1,000 Per Dose in Market if Government Allows, Says Adar Poonawalla
COVID-19 Vaccine: Adar Poonawalla Says SII Ready With Stockpile of 40–50 Million Covishield Doses
Serum Institute to Produce 300 Million Doses of AstraZeneca-Oxford's COVID-19 Vaccine by July 2021, Says CEO Adar Poonawalla
Adar Poonawalla Says Government Should Protect Vaccine Manufacturers From Lawsuits in Case of Adverse Reactions
Oxford COVID-19 Vaccine: SII Responds To Chennai Man's Rs 5 Crore Compensation Notice, Says No Relation Of Medical Condition With Vaccine Trial
Adar Poonawalla Praises Narendra Modi, Says ‘Amazed at How Much Prime Minister Knew About Vaccine’
Covishield Vaccine: Emergency Use Authorisation Request in Two Weeks, Govt Likely to Buy 300-400 Million Doses by July, Says Adar Poonawalla
Oxford COVID-19 Vaccine ‘70% Effective’, Serum Institute Chief Adar Poonawalla Says India Could Give Nod By Year-End
Oxford COVID-19 Vaccine Should be Available for Public by April 2021, Maximum Price Rs 1,000: Seram Institute CEO Adar Poonawalla
COVID-19 Vaccine Covishield May Get Emergency Use Authorisation From India in December 2020, Says Report
When Will COVID-19 Vaccine Covishield, Developed by Oxford-AstraZeneca, Be Available? Adar Poonawalla Responds
After Serum Institute Tweet, Union Health Ministry Says ‘It Disagrees With the Mathematics That Rs 80,000 Crore Is Needed to Vaccinate All Indians’
COVID-19 Vaccine: Rahul Gandhi Echoes Adar Poonawalla's Question, Takes Swipe at PM Narendra Modi's 'Mann Ki Baat'
Google Trends
Live Bot